Navigation Links
Edmonton to be site of world's first industrial scale municipal waste-to-ethanol facility
Date:6/26/2008

between a large urban centre and a biofuel producer to turn municipal waste into ethanol," said Vincent Chornet, President and Chief Executive Officer of Enerkem. "Edmonton is a pioneer in waste management practices and it is setting new standards for other municipalities. We are proud to be working with Edmonton, Greenfield Ethanol and the Government of Alberta through the Alberta Energy Research Institute as partners on this exciting project."

"This next generation biofuels facility will offer drivers a new choice in transportation fuels," said Donald Pierce, President of Greenfield Ethanol's Advanced Biofuels Group. "Greenfield is thrilled to be leading in the development of next generation ethanol along with partners Enerkem, the City of Edmonton and the Province of Alberta-world leaders in providing innovative technologies that help build a sustainable future."

This plant is the first to be announced by Greenfield Ethanol and Enerkem since the recent announcement of their partnership to jointly design, build and operate commercial next generation ethanol plants.

About Edmonton:

This is a city alive with energy and boundless opportunity - a growing economic powerhouse where business thrives and more than a million lives enjoy the freedom to explore, experiment, experience, excel and expect the most out of every day. A place like no other, Edmonton is filled with surprises great and small and a calendar packed with artistic, sporting, theatrical and cultural celebration.

Edmonton is the proud home of the University of Alberta for 100 years. http://www.100years.ualberta.ca
For more information on Edmonton, visit: http://www.edmonton.ca.

Backgrounder

About Greenfield Ethanol

------------------------

- GreenField Ethanol Inc. (ht
'/>"/>

SOURCE Enerkem Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2
2. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
3. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
4. ActivBiotics Assignee Issues First Distribution of Cash to Creditors
5. HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker
6. Start of First Fingertip Payment Pilot in the Netherlands
7. First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease
8. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
9. 220 Companies Place Switzerland First in Biotech Density Per Capita
10. Engineers whip up the first long-lived nanoscale bubbles
11. First Taxane-Based Non-Anthracycline Containing Chemotherapy in Combination With Herceptin (TCH) for HER2 Positive Early Breast Cancer Patients Obtains Approval From the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Corporation (Nasdaq: RGEN ) today announced that ... to support the ongoing development of new treatments ... (MDA). This grant will support the completion ... of a drug candidate for human clinical trials. ... important funding for Repligen,s research but it also ...
(Date:12/15/2009)... Dec. 15 Aethlon Medical, Inc. (OTC ... Jeff Schorey and Dr. Wayne Comper ... Sciences, Inc. (ESI). Both Dr. Schorey and Dr. ... ESI, a wholly owned subsidiary of Aethlon Medical, ... the Hemopurifier®, a medical device being advanced as ...
(Date:12/15/2009)... --The Mosaic Company (NYSE: MOS ) plans ... results and financial tables on Tuesday, January 5, 2010, ... Stock Exchange. Results will be available on Mosaic,s ... host a conference call with presentation slides on Wednesday, ... call will begin at 11:00 a.m. Eastern Standard Time ...
(Date:12/15/2009)... N.Y., Dec. 15 On January 20th, ... Society for Medical Publication Professionals (ISMPP) will be ... London, UK. More than 100 attendees are expected ... for publication professionals, editors, publishers, medical writers and ... medical publications and the impact of guidelines and ...
Breaking Biology Technology:Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2
... vaccine progresses with study designed to select dose for ... Inc. (Nasdaq: NVAX ) announced today vaccination ... its virus-like particle (VLP) seasonal influenza vaccine. Building on ... placebo controlled clinical trial has been designed to evaluate ...
... Novagali Pharma, a French,pharmaceutical ophthalmic company, announces ... (IND) to conduct a Phase III clinical,trial ... glaucoma has been,granted by the U.S. Food ... ocular proprietary BAK-free formulation of latanoprost which,furthermore ...
... Calif., May 5 Poniard Pharmaceuticals, Inc. (Nasdaq: ... Monitoring Committee (DMC), after review of available information regarding ... that the SPEAR (Study of Picoplatin Efficacy After Relapse) ... evaluating the efficacy and safety of picoplatin in patients ...
Other Biology Technology:Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate 2Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate 3Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate 4Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma 2Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 2Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 3Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 4Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 5
(Date:12/16/2009)... more than 4 billion years before humans showed up, ... more. That suggests they may have something to teach ... expert Prof. Eshel Ben-Jacob of the Raymond and Beverly ... study of bacteria, presents compelling evidence to suggest there ... automatically opt for the swine flu H1N1 shot. , ...
(Date:12/16/2009)... 1 GestureTek Inc. today announced ... - a turnkey, portable, plug and play ... entertainment and touring promotions. GestureTek is the ... in camera-enabled gesture recognition technology for interactive ... for quality, the CUBE has TUV, CE, ...
(Date:12/16/2009)... TORONTO, Dec. 7 IgeaCare Solutions Inc. ... assets of the healthcare communications company previously operating ... Solutions will now move forward under new leadership ... Mr. Michael Rochon to the position of Chief ... will focus on providing a superior servicing and ...
Breaking Biology News(10 mins):Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study 50686 1Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study 50686 2Kids With Type 1 Diabetes Often Overweight 50682 1Kids With Type 1 Diabetes Often Overweight 50682 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 1 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 3
... , Fast identification of animal meat for human consumption ... for consumers and producers. Consumption of Iberian pig meat is ... maximum gastronomic quality. In the last years, a booming economic ... Spanish borders: Iberian ham, dried meat, cold meats and cold ...
... London, New Delhi, and Singapore (April 28, 2008) ... more and more common. Weight and eating disorders have ... for more information about how to deal with pediatric ... fifth largest publisher of journals, is launching its newest ...
... inextricably linked. However, new research published in BioMed Centrals ... this may not always hold true, although it may ... , The land and the oceans contain significantly more ... the atmosphere. The amount of CO2 emissions absorbed by ...
Other Biology News:New computer applications allow to classify Iberian pig meat automatically 2